Countries China
China's Mabwell Announces NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND
B7-H3 is a member of the B7 ligand family and is overexpressed in most cancer types but expressed at a low level in normal tissues. In malignant tissues, B...
July 24, 2023 | News
Lynk Pharmaceuticals Doses First Atopic Dermatitis Patient with LNK01004 in Phase Ib Study
The trial was designed to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of LNK01004 ointment in Chinese patie...
July 21, 2023 | News
BioCity Initiates Phase 1 Trial with CDH3-Targeting ADC BC3195, First Patient Dosed
The study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of BC3195 in patients with locally advanced or metastatic solid ...
July 20, 2023 | News
Biotheus Partners with BioNTech in Global Research Collaboration & License Deal
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody and a clinical-stage...
July 20, 2023 | News
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND
9MW2921 is a next generation antibody-drug conjugate (ADC) developed by Mabwell based on IDDC™ (Interchain-Disulfide Drug Conjugate) platef...
July 19, 2023 | News
Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions
PreFluid is a leader in integrated fluid solutionsPreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental indus...
July 19, 2023 | News
Sartorius completes acquisition of Polyplus
Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key com...
July 18, 2023 | News
Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...
July 18, 2023 | News
WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site
The new HP injectable manufacturing line meets Occupational Exposure Limits (OEL) as low as 10 ng/m3 and utilizes fully enclosed isolation systems and...
July 18, 2023 | News
GeneQuantum and InxMed Partner for Innovative ADC Drug Research
According to the agreement, GeneQuantum will provide InxMed with its independently developed, globally leading technologies in site-specific glycan conjuga...
July 17, 2023 | News
Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...
July 17, 2023 | News
Chinese Scientists Extract 'Red Marrow Peptide' from Young Yaks, Promising Breakthrough for Cardiovascular Health
As an important hematopoietic and metabolic immune organ of human body, red blood marrow is known as the systematic "soldier factory". Red blood marrow is ...
July 17, 2023 | News
Harbour BioMed's 2023 Interim Results: Positive Profit Alert Driven by Innovation
Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...
July 14, 2023 | News
Kedrion's global portfolio expands to China to supply human Albumin
Kedrion joined forces with BPL in 2022 This is the first ever approval for a BPL product in China The China Albumin market is the world's largest ...
July 13, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
